🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07394959
Recruiting Not applicable

Hydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention

NCT07394959 · tracked via the Priya Life Science China tracker
Sponsor
Chinese PLA General Hospital
Phase
Not applicable
Started
2024-09-20
Last updated
2026-02-06

Condition(s) studied

Coronary Artery DiseaseChronic Kidney DiseaseElderly

Investigational drug(s) / intervention(s)

Tailored hydration guided by ReDS system

Tailored hydration guided by ReDS system: If initial lung water index is ≥35%, the hydration rate is 1ml/kg/h; If the initial lung water index is \<35% but ≥20%, the hydration rate is 2ml/kg/h; If the initial lung water index is \<20%, the hydration rate is designed to 5ml/kg/h. We re-check the lung water index after the contrast procedure. If the lung water index is \>35% or if there is a more than 2-fold increase in the lung water index compared to pre-procedure, adjust the fluid infusion rate to 0.5ml/kg/h. If the lung water index after the contrast procedure is ≥20% but \<35%, adjust the fluid infusion rate to 1ml/kg/h. If the lung water index after the contrast procedure is still \<20%, adjust the fluid infusion rate to 5ml/kg/h.

Study summary

Explore the effectiveness and safety of tailored hydration guided by lung water index monitor system for prevention of acute kidney injury after percutaneous coronary intervention for elderly patients with renal insufficiency.

Eligibility

Sex
ALL
Min age
60 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 60 years; * Patients with unstable angina pectoris are scheduled for percutaneous coronary intervention; * Patients with chronic renal disease (estimated glomerular filtration rate \< 90 ml/min); * Sign the informed consent form. Exclusion Criteria: * 1\. Acute decompensated severe heart failure or cardiogenic shock; * 2\. Malignant tumors, severe renal failure (estimated glomerular filtration rate \< 30 ml/min); * 3\. Respiratory failure; * 4\. Used contrast media within one week; * 5\. Have allergic to contrast medium

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chinese PLA general hospital Beijing Beijing Municipality Recruiting

More Chinese PLA General Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07394959 on ClinicalTrials.gov ↗ ← All trials in China